172@29@17@241!~!172@29@0@53!~!|news|tags|aurobindo-pharma-limited.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
aurobindo pharma limited
Jump to
9 Results Found
  • Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4 Jun 03, 2020 08:16 PM IST

    Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4

    For the full year 2019-20, revenue from operations was at Rs 23,098.5 crore witnessing a growth of 18.1 percent over 2018-19.

  • FDA points out data integrity lapses at Aurobindo Pharma unit Jun 13, 2019 04:34 PM IST

    FDA points out data integrity lapses at Aurobindo Pharma unit

    The FDA issued Form 483 with 10 observations to Aurobindo Pharma on the plant which was audited by the US drug regulator between May 13 and May 24.

  • Market Headstart: Nifty likely to open flat; 3 stocks which could give 6-7% returns Mar 26, 2019 09:00 AM IST

    Market Headstart: Nifty likely to open flat; 3 stocks which could give 6-7% returns

    Trends on SGX Nifty indicate a flat opening for the broader index in India. Nifty futures were trading around 11,365-level on the Singaporean Exchange.

  • Market Headstart: Nifty likely to open higher; 3 stocks which could give 4-8% return Mar 12, 2019 08:44 AM IST

    Market Headstart: Nifty likely to open higher; 3 stocks which could give 4-8% return

    Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 51.5 points or 0.46 percent. Nifty futures were trading around 11,264- level on the Singaporean Exchange.

  • Nifty may face resistance around 10,970; these 3 stocks could return 14-15% Dec 05, 2018 09:58 AM IST

    Nifty may face resistance around 10,970; these 3 stocks could return 14-15%

    If the index manages to stay above this resistance i.e. 10,970, it will extend the uptrend and rise to 11,085-11,150

  • Market Headstart: Nifty50 likely to open higher; 3 stocks which could give 11-17% return Nov 01, 2018 08:27 AM IST

    Market Headstart: Nifty50 likely to open higher; 3 stocks which could give 11-17% return

    Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 35.5 points or 0.34 percent. Nifty futures were trading around 11,422-level on the Singaporean Exchange.

  • Market Headstart: Nifty likely to open around 10,200; 3 stocks which could give 6-7% return Oct 23, 2018 08:43 AM IST

    Market Headstart: Nifty likely to open around 10,200; 3 stocks which could give 6-7% return

    Trends on SGX Nifty indicate a negative opening for the broader index in India, a loss of 71 points or 0.69 percent. Nifty futures were trading around 10,181- level on the Singaporean Exchange.

  • US FDA approves Aurobindo Pharma's generic Ertapenem Injection Jun 26, 2018 01:50 PM IST

    US FDA approves Aurobindo Pharma's generic Ertapenem Injection

    Ertapenem injection is used for the treatment of moderate to severe infections caused by susceptible bacteria.

  • Aurobindo Pharma gets final USFDA approval Mar 21, 2017 08:52 AM IST

    Aurobindo Pharma gets final USFDA approval

    "Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1 FY18 (in US)," it said.

Sections